New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build

New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions

ValueSet: NZ cancer grade

Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/canshare-grade Version: 0.1.0
Active as of 2024-11-02 Computable Name: canshare-grade
Other Identifiers: http://canshare.co.nz/fhir/NamingSystem/valuesets#canshare-grade

The grade of a cancer

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

Generated Narrative: ValueSet canshare-grade

version: 1; Last updated: 2024-11-05 17:15:33+1300; Language: en-x-sctlang-23162100-0210105

  • Include codes fromhttp://snomed.info/sct where constraint = < 384740007 |Finding of grade (finding)| OR < 370114008 |Histological grades (qualifier value)|

 

Expansion

Generated Narrative: ValueSet canshare-grade

version: 1; Last updated: 2024-11-05 17:15:33+1300; Language: en-x-sctlang-23162100-0210105

Expansion based on SNOMED CT 21000210109 edition 01-Oct 2024

This value set contains 100 concepts

CodeSystemDisplay - English (English, en)
  369781009http://snomed.info/sctDCIS nuclear pleomorphism, grade 1: monotonous nuclei, 1.5 - 2.0 RBC diameters, with finely dispersed chromatin and only occasional nucleoli
  369782002http://snomed.info/sctDCIS nuclear pleomorphism, grade 2: neither nuclear grade 1 nor nuclear grade 3
  369783007http://snomed.info/sctDCIS nuclear pleomorphism, grade 3: Markedly pleomorphic nuclei, usually >2.5 RBC diameters, with coarse chromatin and multiple nucleoli
  1290245004http://snomed.info/sctDifferentiating neuroblastoma
  1290302009http://snomed.info/sctFIGO (International Federation of Gynecology and Obstetrics) grading system grade 1
  1290303004http://snomed.info/sctFIGO (International Federation of Gynecology and Obstetrics) grading system grade 2
  1290304005http://snomed.info/sctFIGO (International Federation of Gynecology and Obstetrics) grading system grade 3
  396193002http://snomed.info/sctFuhrman nuclear grade finding
  54102005http://snomed.info/sctG1 grade
  369724004http://snomed.info/sctG1: 5 percent or less non-squamous solid growth
  369720008http://snomed.info/sctG1: Nuclei round, uniform, approximately 10 µ; nucleoli inconspicuous or absent
  1155701009http://snomed.info/sctG1: Well differentiated
  369716009http://snomed.info/sctG1: Well differentiated (greater than 95 percent gland forming)
  1155706004http://snomed.info/sctG1: Well differentiated neuroendocrine neoplasm
  476251000210106http://snomed.info/sctG1: Well differentiated neuroendocrine neoplasm, typical carcinoid of thorax
  1663004http://snomed.info/sctG2 grade
  369725003http://snomed.info/sctG2: 6-50 percent non-squamous solid growth
  1155703007http://snomed.info/sctG2: Moderately differentiated
  369717000http://snomed.info/sctG2: Moderately differentiated (50-95 percent gland forming)
  369721007http://snomed.info/sctG2: Nuclei slightly irregular, approximately 15 µ; nucleoli evident
  1155710001http://snomed.info/sctG2: Well differentiated neuroendocrine neoplasm
  476241000210108http://snomed.info/sctG2: Well differentiated neuroendocrine neoplasm, atypical carcinoid of thorax
  61026006http://snomed.info/sctG3 grade
  369726002http://snomed.info/sctG3: More than 50 percent non-squamous solid growth
  369722000http://snomed.info/sctG3: Nuclei very irregular, approximately 20 µ; nucleoli large and prominent
  1155704001http://snomed.info/sctG3: Poorly differentiated
  369718005http://snomed.info/sctG3: Poorly differentiated (5-49 percent gland forming)
  1155711002http://snomed.info/sctG3: Well differentiated neuroendocrine neoplasm
  258245003http://snomed.info/sctG4 grade
  369723005http://snomed.info/sctG4: Nuclei bizarre and multilobated, 20 µ or greater, nucleoli prominent, chromatin clumped
  1155702002http://snomed.info/sctG4: Undifferentiated
  369719002http://snomed.info/sctG4: Undifferentiated (less than 5 percent gland forming)
  1268929003http://snomed.info/sctGB: Borderline tumour
  384741006http://snomed.info/sctGrade cannot be determined
  477281000210103http://snomed.info/sctGrade determined
  60815008http://snomed.info/sctGrade not determined
  1155705000http://snomed.info/sctGX: Histologic grade cannot be assessed
  1155712009http://snomed.info/sctGX: Neuroendocrine neoplasm grade cannot be assessed
  369767007http://snomed.info/sctHigh grade (lymphoma)
  395530002http://snomed.info/sctHigh grade (poorly differentiated to undifferentiated)
  399611001http://snomed.info/sctHigh grade histologic differentiation
  1155707008http://snomed.info/sctHigh histologic grade
  476601000210107http://snomed.info/sctHigh poorly differentiated histologic grade
  373372005http://snomed.info/sctHistological grade finding
  405986005http://snomed.info/sctIntermediate grade histologic differentiation
  1286893008http://snomed.info/sctIntermediate histologic grade
  332391000210102http://snomed.info/sctInternational Federation of Gynecology and Obstetrics grade 1
  332401000210104http://snomed.info/sctInternational Federation of Gynecology and Obstetrics grade 2
  332411000210102http://snomed.info/sctInternational Federation of Gynecology and Obstetrics grade 3
  332381000210104http://snomed.info/sctInternational Federation of Gynecology and Obstetrics grade finding
  1290294004http://snomed.info/sctInternational Federation of Gynecology and Obstetrics grading system
  1279715000http://snomed.info/sctInternational Society of Urological Pathology grade group 1 (Gleason score 3 + 3 = 6)
  1279714001http://snomed.info/sctInternational Society of Urological Pathology grade group 2 (Gleason score 3 + 4 = 7)
  1279716004http://snomed.info/sctInternational Society of Urological Pathology grade group 3 (Gleason score 4 + 3 = 7)
  1279718003http://snomed.info/sctInternational Society of Urological Pathology grade group 4 (Gleason score 3 + 5 = 8)
  1279717008http://snomed.info/sctInternational Society of Urological Pathology grade group 4 (Gleason score 4 + 4 = 8)
  1279719006http://snomed.info/sctInternational Society of Urological Pathology grade group 4 (Gleason score 5 + 3 = 8)
  1279720000http://snomed.info/sctInternational Society of Urological Pathology grade group 5 (Gleason score 4 + 5 = 9)
  1279721001http://snomed.info/sctInternational Society of Urological Pathology grade group 5 (Gleason score 5 + 4 = 9)
  1279722008http://snomed.info/sctInternational Society of Urological Pathology grade group 5 (Gleason score 5 + 5 = 10)
  1515521000004104http://snomed.info/sctInternational Society of Urological Pathology histologic grade group
  1525761000004109http://snomed.info/sctInternational Society of Urological Pathology histologic grade group 1
  1525771000004101http://snomed.info/sctInternational Society of Urological Pathology histologic grade group 2
  1525781000004103http://snomed.info/sctInternational Society of Urological Pathology histologic grade group 3
  1525791000004100http://snomed.info/sctInternational Society of Urological Pathology histologic grade group 4
  1525801000004104http://snomed.info/sctInternational Society of Urological Pathology histologic grade group 5
  369766003http://snomed.info/sctLow grade (lymphoma)
  395529007http://snomed.info/sctLow grade (well to moderately differentiated)
  399415002http://snomed.info/sctLow grade histologic differentiation
  425037004http://snomed.info/sctLow grade lymphoma, stage 1
  1155708003http://snomed.info/sctLow histologic grade
  476591000210102http://snomed.info/sctLow well-moderately differentiated histologic grade
  384812005http://snomed.info/sctModerately differentiated
  373377004http://snomed.info/sctModerately differentiated histological grade finding
  384668003http://snomed.info/sctNottingham Combined Grade cannot be determined
  373378009http://snomed.info/sctNottingham Combined Grade finding
  369790002http://snomed.info/sctNottingham Combined Grade I: 3-5 points
  369791003http://snomed.info/sctNottingham Combined Grade II: 6-7 points
  369792005http://snomed.info/sctNottingham Combined Grade III: 8-9 points
  1287024003http://snomed.info/sctNottingham combined histologic grade 1
  1287025002http://snomed.info/sctNottingham combined histologic grade 2
  1287026001http://snomed.info/sctNottingham combined histologic grade 3
  1287020007http://snomed.info/sctNottingham grade system for primary malignant neoplasm of breast
  1287460004http://snomed.info/sctNottingham scoring system for primary malignant neoplasm of breast
  1287021006http://snomed.info/sctNottingham scoring system for primary malignant neoplasm of breast score 1
  1287022004http://snomed.info/sctNottingham scoring system for primary malignant neoplasm of breast score 2
  1287023009http://snomed.info/sctNottingham scoring system for primary malignant neoplasm of breast score 3
  384736003http://snomed.info/sctNuclear grade finding
  263843001http://snomed.info/sctPoorly differentiated
  373373000http://snomed.info/sctPoorly differentiated histological grade finding
  313147000http://snomed.info/sctTumour grade G0
  263918006http://snomed.info/sctUndifferentiated
  373374006http://snomed.info/sctUndifferentiated histological grade finding
  263933003http://snomed.info/sctWell differentiated
  373375007http://snomed.info/sctWell differentiated histological grade finding
  396921005http://snomed.info/sctWHO grade finding for central nervous system tumour
  396922003http://snomed.info/sctWHO grade I (central nervous system tumour)
  396923008http://snomed.info/sctWHO grade II (central nervous system tumour)
  396924002http://snomed.info/sctWHO grade III (central nervous system tumour)
  396925001http://snomed.info/sctWHO grade IV (central nervous system tumour)

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code